Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Detection of bovine leukemia virus, Epstein-Barr virus and human papillomavirus in breast cancer tissues of Egyptian patients
Multiple viral co-existence found in 18% of PCR positive cases.
»
07/01/25
Retrospective comparison between breast cancer tissue- and blood-based next-generation sequencing results in detection of PIK3CA, AKT1, and PTEN alterations
Minimally invasive option to identify clinically relevant PIK3CA/AKT1/PTEN short variants.
»
07/01/25
Skin melanoma cells produce diverse gelsolin (GSN) isoforms, which play non-redundant roles in cell proliferation and motility
Cells producing GSN-A invade more efficiently.
»
07/01/25
Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer
I + A treatment associated with higher prevalence of immune-related pneumonia.
»
07/01/25
Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study
MRI complements CE by enhancing staging accuracy.
»
07/01/25
Evaluation of 30-day mortality rate following intravenous systemic anticancer therapy: a retrospective analysis
Overall 30-day mortality rate post-SACT 7%.
»
07/01/25
Safety and efficacy of atezolizumab/bevacizumab in unresectable hepatocellular carcinoma--a multicentric study
Real-world OS and PFS rates lower than those of IMBrave trial.
»
07/01/25
Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials
Efficacy of tamoxifen, raloxifene and AIs confirmed.
»
07/01/25
Long-term weight change among breast cancer patients treated with chemotherapy: a longitudinal study over 13 years
Type of chemotherapy, use of hormone therapy, age at inclusion, menopausal status not statistically significantly associatied.
»
07/01/25
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2-advanced or metastatic breast cancer: phase 1/2 study results
Most common grade 3 TEAE transient neutropenia.
»
07/01/25
< Prev
Next >